| Literature DB >> 35743019 |
Yuemeng Zhu1, Yidi Zhang1, Yanmin Zhou1.
Abstract
In recent years, bone tissue engineering (BTE), as a multidisciplinary field, has shown considerable promise in replacing traditional treatment modalities (i.e., autografts, allografts, and xenografts). Since bone is such a complex and dynamic structure, the construction of bone tissue composite materials has become an attractive strategy to guide bone growth and regeneration. Chitosan and its derivatives have been promising vehicles for BTE owing to their unique physical and chemical properties. With intrinsic physicochemical characteristics and closeness to the extracellular matrix of bones, chitosan-based composite scaffolds have been proved to be a promising candidate for providing successful bone regeneration and defect repair capacity. Advances in chitosan-based scaffolds for BTE have produced efficient and efficacious bio-properties via material structural design and different modifications. Efforts have been put into the modification of chitosan to overcome its limitations, including insolubility in water, faster depolymerization in the body, and blood incompatibility. Herein, we discuss the various modification methods of chitosan that expand its fields of application, which would pave the way for future applied research in biomedical innovation and regenerative medicine.Entities:
Keywords: bone tissue engineering; cross-linking; modified chitosan; structure modification
Mesh:
Substances:
Year: 2022 PMID: 35743019 PMCID: PMC9224397 DOI: 10.3390/ijms23126574
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 6.208
Summary of the following different types of modifications of chitosan, fabrication techniques, bioactive molecules, and experimental model system in the study of bone regeneration in vitro and in vivo.
| Modification | Fabrication | Materials | Effect | Cell/Model | Ref. |
|---|---|---|---|---|---|
| Physically cross-linked | ice template-assisted freeze-drying | EO-loaded CS/Dex | Exhibit antioxidant, antifungal properties and the inhibition of | - | [ |
| freeze-drying | nanoporous chitin hydrogels | Enhance the strength and Young’s modulus of hydrogel, mBMSC adhesion, and proliferation | mBMSC | [ | |
| direct ink writing (DWI) | CS/PVA | Promote toughness performance | - | [ | |
| double network | CS/PVA/HAp | Increase cell adhesion, proliferation, OCN, ALP, COL I, and osteochondral repair efficacy | Rat bone marrow mesenchymal stem cells (rBMSCs) and L929 cells (Mouse fibroblast cell line)/New Zealand white rabbits with a bone defect (5 mm in diameter and 8 mm deep) in the lateral femoral condyle | [ | |
| Aldehyde-crosslinking | freeze-drying | CS/HA/β-TCP | Promote biological performance, metabolic activity, ALP expression, cell morphology, cell/scaffold interaction, and gene expression | MG63 human osteoblastic-like cells | [ |
| freeze-drying | CS/vanillin hydrogel | Achieve a good balance between self-healing | - | [ | |
| emulsion method | CS/vanillin hydrogel | Provide favorable cell attachment and biocompatibility | MG63 cell/ | [ | |
| freeze-drying | vanillin-CS/CS | Exhibit suitable viscosity values and shear thinning behavior for 3D printing applications | - | [ | |
| freeze-drying | Cinnamaldehyde/CS | Show thermal characteristics and stability and synergistic antibacterial activity against | [ | ||
| Genipin cross-linking | CS and hyaluronic acid solutions PEC+BMP-2 | Control the swelling ratio and degradation of PEC and achieve quite a high loading efficacy, prolonged, and sustained BMP-2 release profile | MC3T3-E1 cells | [ | |
| mixing | gentamycin sulfate (GS)-loaded CMCS hydrogel | Achieve superb inhibition of bacterial growth and biofilm formation of | MC3T3-E1 cells | [ | |
| electrospinning | CS/HA nanofibers | Increase in Young’s modulus and osteoinductive bioactivity | Murine 7F2 osteoblast-like cells | [ | |
| mixing | CS/methylcellulose | Enhance fibroblast, endothelial, and osteoblast proliferation and adhesion | Osteoblasts, fibroblasts, and HUVECs | [ | |
| DWI and freeze-drying | HA/CS composite scaffolds | Friendly environment, increase cell population, levels of viability, and attachment | MG63 human osteoblast-like cells | [ | |
| self-assembly | HA/GO/CS composite hydrogel | Improve the microstructure and mechanical strength. Balance the rigidity and toughness of the composite hydrogel | Rat bone marrow mesenchymal stem cells (rBMSCs) | [ | |
| Tripolyphosphate (TPP) cross-linking | coacervation and lyophilization | nHA/CS/TPP Scaffolds | Exhibit highest ultimate compressive strength and show good osteoblast adhesion and proliferation | OB-6 line cell | [ |
| freeze-drying | CS/Gel/β-TCP scaffolds | Show mechanical improvements, bioactivity, high proliferation rate, high extracellular calcium deposition, excellent cell adhesion, and characteristic osteoblast cell morphology | Human osteoblast cells (CRL-11372) (hOB) | [ | |
| freeze-drying | HA/β-TCP/CS composites | Show good swelling properties, and higher levels of cell proliferation and growth | Human osteoblast-like cells (Saos-2) and mouse fibroblastic-like cells (L929) | [ | |
| Glycerylphytate (G1Phy) | 3d-printing and photopolymerization | GelMA/CS scaffold | Exhibit excellent shape fidelity, resolution, swelling behavior, and mechanical and biological properties; enhance cell adhesion and proliferation | L929 fibroblasts | [ |
| Carbodiimide and citric acid | extruded in a coagulant bath using viscose-type stainless steel spinneret | citrate–CS fibers | Improve the mechanical property, higher stability against enzymatic degradation and hydrophobicity, and superior bio-mineralization | MSCs | [ |
| Photo-crosslinking | UV light | MCS/TPVA (Darocur 2959) | Exhibit rapid gelation behavior, improved stiff and compressive strength. Promote L929 cell attachment and proliferation | L929 cell | [ |
| visible blue light with riboflavin | CS-MTT hydrogel | Recruit native cells and promote calvarial healing without the delivery of additional therapeutic agents or stem cells | male CD-1 nude mice | [ | |
| blue light (420–460 nm) | ChI-MA/GO | Showe intermediate platelet aggregation hemolytic tendencies, enhance tissue regeneration | NHOst cells | [ | |
| Enzymatic-crosslinking | Standard carbodiimide coupling method | HPP-GC + BMP(HRP + H2O2) | Localize osteoprogenitor recruitment and osteogenesis | Col3.6 rat critical sized bilateral calvarial defect model | [ |
| Carboxymethyl chitosan, CMCS | electrospinning | CMCS/HA | Increase the ALP activity and Runx2 expression, promote new bone formation and maturation | mBMSCs | [ |
| electrospinning | PCL/CMCS nanofibrous scaffolds | Adjust the viscosity and charge density and exhibited excellent initial cell attachment and proliferation | human osteoblast cells (MG63) | [ | |
| freeze-drying | NOCC/FD composite hydrogel | Enhance the proliferation, ALP activity, and mineralization of osteoblast cells | L929 mouse fibroblasts and 7F2 osteoblast cell | [ | |
| freeze-drying | SF/CMCS/CNCs/Sr-HAp | Maintain high porosity with a lower swelling ratio, enhanced protein adsorption and ALP activity | bone mesenchymal stem cell (BMSC) | [ | |
| Hydroxypropyltrimethyl ammonium chloride chitosan (HACC) | 3D-printing | PLGA/HA/HACC composite scaffold | Favor cell attachment, proliferation, spreading, and osteogenic differentiation and exhibit good neovascularization and tissue integration | human bone marrow-derived mesenchymal stem cells (hBMSCs) | [ |
| solvent casting-particulate leaching method | silica/HACC/zein scaffold | Exhibit long-lasting antibacterial activity against | Rabbit model of critical-sized radius bone defect | [ | |
| PTFE mould | HACC-PMMA | Improve properties, stem cell proliferation, osteogenic differentiation, and osteogenesis-associated gene expression | human mesenchymal stem cells (hMSCs) | [ | |
| Sulfated chitosan (SCS) | - | 2-N,6-O- SCS + BMP-2 | Exhibit a higher cell viability and sprouting ability, secrete more VEGF and NO, and improve the angiogenic potential | Rat bone marrow stromal cells (BMSCs) | [ |
| solution casting | SCS coated on poly(d,l-lactide) (PDLLA) | Increase osteogenic- and angiogenic-related gene and protein expression | Mouse preosteoblast cells (MC3T3-E1s) and human umbilical vein endothelial cells (HUVECs) | [ | |
| - | 2-N,6-O- SCS + BMP-2 | Enhance BMP-2 bioactivity to induce osteoblastic differentiation in vitro and in vivo by promoting the BMP-2 signaling pathway | C2C12 cells | [ | |
| Glycol chitosan (GCS) | solvent cast and evaporation | nHA/GCS composites | No cytotoxicity and promotion of cell ingrowth and osteoconduction | osteoblastic-like (SAOS) and embryonic cell lines (HEK293T) | [ |
| solvent cast and evaporation | CHA/ SF/GCS/DF-PEG self-healing hydrogel + BMP-2 | Promote osteogenic differentiation of mOPCs and promote the proliferation and migration of HUVECs | C57BL/6 suckling rat | [ | |
| electrostatic interaction | GCS-HA NPs + PEGDA+ SrRNPs-H | Increase the level of bone regeneration | Dorsal incision around the lumbar and sacral pine area of male Wistar rats | [ | |
| Guanidinylated chitosan (GC) | sol–gel chemistry and freeze-drying | Sulfonate and carboxylate-containing chitosan/silica hybrid composites | Showed a substantial effect on the mineralization of calcium phosphate and was more efficient to induce heterogeneous nucleation and growth of hydroxyapatite | - | [ |
| - | GC/PANI-containing self-healing semi-conductive waterborne scaffolds | Exhibit excellent shape memory properties and shape recovery ratio, enhanced cell attachment, COL-1, ALP, RUNX2, and OCN expression | Human adipose-derived mesenchymal stem cells (hADSCs) | [ | |
| mixing | LNSs/GC | Show inherent osteogenic properties, a versatile moldable vehicle, facilitating handling and osteogenic potential | Mouse bone marrow stromal cell line (BMSCs, D1 ORL UVA [D1], D1 cell, CRL-12424) | [ | |
| Grafted with PLA | electrospun | CS/PLA/HA | Enhance proliferation of MC3T3-E1 cells used in applications as coating materials on medical devices | MC3T3-E1 cells | [ |
| Grafted with HPMC | coupling reagent-mediated approach | CS/HPMC | Highly water-soluble across a wide pH range, high pH buffering capacity, and a high drug encapsulation efficiency | Metronidazole, methylene blue, tetracycline hydrochloride, and mometasone furoate as drug models | [ |
| Grafted with CMC | Freeze-drying | CS/HPMC/ mesoporous wollastonite | Cyto-friendly nature to human osteoblastic cells, confirmed by calcium deposition and expression of an osteoblast-specific microRNA | MG-63 | [ |
| Grafted with cycle RGD peptide | noncovalent method | CS/cRGD/GO | Provide a multifunctional drug delivery system and can be efficiently loaded with a number of therapeutic agents for biomedical applications | hepatoma cells (Bel-7402, SMMC-7721, HepG2) | [ |
| Grafted with HVP-aldehyde peptide | mixing | CS/HVP | Support the adhesion of osteoblasts, the formation of elongated cell shapes, and increased osteoblast differentiation. | Human (h) osteoblast cells | [ |
Overview of CS-based biomaterials in preclinical and clinical trials.
| Animals/Volunteers (Total) | Incisions/Defects/Cells | Chitosan-Based Form | Effects | Ref. | |
|---|---|---|---|---|---|
| Preclinical trials | Beagles (n/d) | Open skin wounds on the dorsal side | 20 mg/wound (2 × 2 cm) | Activate immunocytes and inflammatory cells | [ |
| Mail Wistar rats (60) | Bone defects measuring 2 mm in diameter in both tibias | CS/D. ambrosioides spheres | Faster bone regeneration and a controlled release of the extract | [ | |
| New Zealand white rabbits (20) | Undergoing TKA surgery and implanted with | CMCS hydrogel | Reduce the inflammatory response around rabbit knee prostheses, affect the OPG/RANKL/RANK signaling pathway, and promote osteogenesis. | [ | |
| Clinical trials | Patients undergoing abdominal surgery | Wound incisions | CS membrane | An effective antimicrobial and procoagulant and promote wound repair by providing a suitable environment for beneficial microbiota | [ |
| Patients aged 50–70 years old undergoing total or elective hip replacement (n/d) | Human bone marrow stromal cells | CS immobilized glasses | Stimulate fast osteoblast response, displaying rapid cell spreading and cytoskeleton reorganization | [ |
n/d: No data specified.
Advantages and limitations of modified methods of chitosan.
| Cross-linking Method | Strength | Limit |
|---|---|---|
| Physical cross-linking | Safety of biomedicine | Reversible Unstable |
| Chemical cross-linking | Easy to operate Stability Excellent mechanical properties Adjustable degradation properties | Toxic cross-linking agents Difficulty in sterilization |
| Enzymatic cross-linking | Under normal physiological conditions Highly biocompatible | Substrate specificity |
Figure 1The scheme of preparing the CS/PVA hydrogel.
Figure 2Scheme of developing and characterizing the composite scaffolds by combining biomimetically synthesized HAp nanocrystals in the presence of natural biomolecules.
Figure 3Schematic drawing of the preparation of the chitosan hydrogel.
Figure 4Scheme of developing and characterizing the microparticles of nano-hydroxyapatite, chitosan, and tripolyphosphate.
Figure 5Reaction schematic and photobiology of MCS/TPVA hydrogels.
Figure 6Scheme of developing and characterizing the microparticles of rhBMP-2 loaded HPP-GC hydrogel, (*) non-degraded gel, NB: new bone.
Cross-linking mechanism of different cross-linking agents and chitosan.
| Cross-Linking Agents | Cross-Linking Mechanism |
|---|---|
| Glutaraldehyde(GA) |
|
| Vanillin |
|
| Genipin |
|
| Tripolyphosphate, TPP |
|
| Carbodiimide(NHS/EDC) |
|
| Enzymatic-cross-linking (HRP) |
|
| Photoinitiators |
|
| Methylmethacrylate chitosan, ChMA |
|
Figure 7Osteogenesis gene expression of the SF-based scaffolds SF/CMCS, SF/CMCS/CNCs, SF/CMCS/Sr-Hap, and SF/CMCS/Sr-HAp/CNCs: (a) ALP, (b) RUNX2, (c) OCN, (d) OPN, (e) BSP, (f) COL-1. Probability (p) value of b0.05(*) is considered as significant and (p) value of b0.01(**) is considered to be highly significant. Copyright © [215] 2019 Elsevier B.V.
Figure 8(a) Relative ALP activity of hMSCs after 6, 10, and 14 days of culture, (*) denotes a significantly lower ALP activity of cells than that on the PMMA surface at day 6 and day 10 (p < 0.01), (#) denotes a significantly lower ALP activity level compared to that on the PMMA-C and PMMA-H at day 6 and day 10 (p < 0.05); (b) Image of the positive ALP staining on the four PMMA-based bone cements on day 14; (c) Colorimetric quantitative analysis of the extracellular matrix mineralization on the samples after three weeks of incubation, (*) denotes significantly lower mineralization than the mineralization on the PMMA (p < 0.01). ($) denotes significantly lower mineralization than the mineralization on PMMA-H (p < 0.01); (d) Alizarin Red staining showing that mineralization was consistent with the quantitative analysis of mineralization; (e,f) Relative osteogenesis-related gene expressions of the hMSCs cultured on the PMMA-G and PMMA-H bone cement for 14 days and 21 days based on real-time PCR, # p < 0.05 compared with PMMA-G. Data were redrawn from [224].
Figure 9(a) Cell viability of BMSCs treated with BMP-2 and BMP-2/SCS determined by the MTT assay, (*) denotes significant difference (p < 0.05) as compared to the control group, (**) denotes p < 0.05 compared to both control and BMP-2 group; (b)Secretion kinetics of VEGF from BMSCs after culturing with BMP-2 and BMP-2/SCS. (c) Intracellular NO secretion of BMSCs in the culture medium (control group), BMP-2, and the BMP-2/SCS group, (d) Immunohistochemican anti-CD31 staining of the ectopic bone section, and (e) The statistical analysis of blood vessels after the microvessel counting was conducted at 200×. Probability (p) value of b0.05(*) is considered as significant and (p) value of b0.01(**) is considered to be highly significant. Data were redrawn from [230].
Figure 10Schematic illustration of supramolecular hydrogels with self-healing and injectable properties for bone regeneration with no need for growth factors, self-healing processes of DBM-loaded supramolecular hydrogels, and of two DBM-loaded hydrogels after attachment directly. Modified from [242].
Structural formula of structure-modified chitosan.
| CS derivates | Chemical formula |
|---|---|
| Carboxymethyl chitosan, CMC |
|
| Hydroxypropyltrimethyl ammonium chloride chitosan, HACC |
|
| Sulfated chitosan, SCS |
|
| Glycol chitosan, GCS |
|
| Guanidinylated chitosan, GC |
|